DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹9,042 Cr | ₹8,030 Cr | ₹7,249 Cr | ₹6,676 Cr | ₹4,964 Cr |
What is the latest Sundry Debtors ratio of DR REDDYS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹9,042 Cr |
| Mar2024 | ₹8,030 Cr |
| Mar2023 | ₹7,249 Cr |
| Mar2022 | ₹6,676 Cr |
| Mar2021 | ₹4,964 Cr |
How is Sundry Debtors of DR REDDYS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,042 Cr | 12.61 | |
| Mar2024 | ₹8,030 Cr | 10.78 | |
| Mar2023 | ₹7,249 Cr | 8.57 | |
| Mar2022 | ₹6,676 Cr | 34.49 | |
| Mar2021 | ₹4,964 Cr | - | |
Compare Sundry Debtors of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹110,626.2 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹92,610.8 Cr | 0.8% | 7.7% | -2.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1% |
4% |
16.6% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses